Urinary retention caused after fluoxetine-risperidone combination

Journal of Psychopharmacology

Volumn 15, Issue 2, 2001, Pages 142-143

  Bozikas, V ^a   Petrikis, P ^a   Karavatos, A ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

Extrapyramidal side effects; Fluoxetine; Risperidone; Urinary retention

Indexed keywords

AMANTADINE; DOPAMINE; FLUOXETINE; LORAZEPAM; OLANZAPINE; RISPERIDONE; SEROTONIN;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DIAGNOSTIC PROCEDURE; DISEASE COURSE; DOPAMINERGIC ACTIVITY; EXTRAPYRAMIDAL SYMPTOM; HUMAN; MALE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SCHIZOPHRENIA; SEROTONINERGIC SYSTEM; TREATMENT OUTCOME; URINE RETENTION;

ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; ANTIPSYCHOTIC AGENTS; BASAL GANGLIA DISEASES; DELUSIONS; DRUG COMBINATIONS; FLUOXETINE; HUMANS; MALE; MIDDLE AGED; RISPERIDONE; URINARY RETENTION;

EID: 0034931369     PISSN: 02698811     EISSN: None     Source Type: Journal    
DOI: 10.1177/026988110101500201     Document Type: Article

References (17)

1. Treatment of overactive bladder: Drug mechanisms
2. Extrapyramidal symptoms with selective serotonin reuptake inhibitors
3. Therapeutic drug monitoring of risperidone using a new, rapid HPLC method: Reappraisal of interindividual variability factors
4. Critical analysis and comparison of the side-effect and safety profiles of the new antipsychotics
5. Adverse effects of the atypical antipsychotics
6. Fluoxetine and extrapyramidal side effects
7. Inhibition of human cytochrome P450-3A isoforms by fluoxetine and norfluoxetine: In vitro and in vivo studies
8. 2 receptors
9. Pharmacokinetics of selective serotonin reuptake inhibitors
10. Movement disorders associated with the serotonin selective inhibitors
11. Risperidone drug monitoring: A useful clinical tool?
12. Cytochrome P450 2D6 genotype and steady state plasma levels of risperidone and 9-hydroxyrisperidone
13. A rating scale for extrapyramidal side effects
14. Selective serotonin reuptake inhibitors
15. 1 receptor agonist SKF 38393 suppresses detrusor hyperreflexia in the monkey with parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)
16. Urinary incontinence and depression